• Effectively treats acne vulgaris
  • The only topical erythromycin gel on the market
  • Provides convenient, spreadable coverage
  • Used once or twice a day for 6 to 8 weeks


Full Prescribing Information

  • ERYGEL┬«(Erythromycin) Topical Gel USP, 2% is contraindicated in individuals who have shown hypersensitivity to any of its components.

  • Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to administration of antibacterial agents.

  • ERYGEL is for topical use only, not for ophthalmic use. Avoid contact with eyes and all mucus membranes.

  • Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating or abrasive agents. If irritation or dermatitis occurs, ERYGEL should be discontinued.

  • Safety and effectiveness in pediatric patients have not been established.

  • In clinical trials, the most common adverse events were burning (25%), and occasional peeling, dryness, itching, erythema and oiliness. Irritation of the eyes and tenderness of the skin have also been reported with the topical use of erythromycin.

  • The contents of ERYGEL are flammable; patients should avoid fire, flame and/or smoking during and immediately following application.

Erygel Topical Gel USP, 2% is indicated for the topical treatment of acne vulgaris.

Prestium Prescription
Savings Program